Ribosome profiling in mouse hippocampus: plasticity-induced regulation and bidirectional control by TSC2 and FMRP

Mol Autism. 2020 Oct 14;11(1):78. doi: 10.1186/s13229-020-00384-9.

Abstract

Background: Mutations in TSC2 are the most common cause of tuberous sclerosis (TSC), a disorder with a high incidence of autism and intellectual disability. TSC2 regulates mRNA translation required for group 1 metabotropic glutamate receptor-dependent synaptic long-term depression (mGluR-LTD) and behavior, but the identity of mRNAs responsive to mGluR-LTD signaling is largely unknown.

Methods: We utilized Tsc2+/- mice as a mouse model of TSC and prepared hippocampal slices from these animals. We induced mGluR-LTD synaptic plasticity in slices and processed the samples for RNA-seq and ribosome profiling to identify differentially expressed genes in Tsc2+/- and following mGluR-LTD synaptic plasticity.

Results: Ribosome profiling reveals that in Tsc2+/- mouse hippocampal slices, the expression of several mRNAs was dysregulated: terminal oligopyrimidine (TOP)-containing mRNAs decreased, while FMRP-binding targets increased. Remarkably, we observed the opposite changes of FMRP binding targets in Fmr1-/y hippocampi. In wild-type hippocampus, induction of mGluR-LTD caused rapid changes in the steady-state levels of hundreds of mRNAs, many of which are FMRP targets. Moreover, mGluR-LTD failed to promote phosphorylation of eukaryotic elongation factor 2 (eEF2) in TSC mice, and chemically mimicking phospho-eEF2 with low cycloheximide enhances mGluR-LTD in TSC mice.

Conclusion: These results suggest a molecular basis for bidirectional regulation of synaptic plasticity and behavior by TSC2 and FMRP. Our study also suggests that altered mGluR-regulated translation elongation contributes to impaired synaptic plasticity in Tsc2+/- mice.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Fragile X Mental Retardation Protein / metabolism*
  • Fragile X Syndrome / pathology
  • Fragile X Syndrome / physiopathology
  • Hippocampus / metabolism*
  • Methoxyhydroxyphenylglycol / analogs & derivatives
  • Methoxyhydroxyphenylglycol / pharmacology
  • Mice, Inbred C57BL
  • Neuronal Plasticity*
  • Peptide Elongation Factor 2 / metabolism
  • Protein Binding
  • Protein Biosynthesis
  • RNA 5' Terminal Oligopyrimidine Sequence / genetics
  • Receptors, Metabotropic Glutamate / metabolism
  • Ribosomes / metabolism*
  • Signal Transduction / drug effects
  • Tuberous Sclerosis Complex 2 Protein / metabolism*

Substances

  • Peptide Elongation Factor 2
  • Receptors, Metabotropic Glutamate
  • Tuberous Sclerosis Complex 2 Protein
  • metabotropic glutamate receptor type 1
  • Fragile X Mental Retardation Protein
  • Methoxyhydroxyphenylglycol
  • 3,4-dihydroxyphenylglycol